Drugs / Intact Pro
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06648850 | May 2026 → Mar 2027 expected | baldness, male pattern, telogen effluvium | Applied Biology, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intact Pro | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06648850 ↗ |
| Route | Topical | “Phenylephrine Topical 0.25% + Intact Pro Topical” NCT06648850 ↗ |